Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr₹4,201 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹5,967 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹5,967 Cr
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr
Mar2021₹4,201 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹5,967 Cr
2.55
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr
11.63
Mar2021 ₹4,201 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,925.2 Cr 3% 9.5% 61.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3%

9.5%

61.3%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses